CNO Financial Group, Inc.·4

Jul 1, 4:10 PM ET

Bhojwani Gary C. 4

4 · CNO Financial Group, Inc. · Filed Jul 1, 2026

Research Summary

AI-generated summary of this filing

Updated

CNO CEO Gary Bhojwani Exercises Options and Sells Shares

What Happened

  • Gary C. Bhojwani, Chief Executive Officer of CNO Financial Group (CNO), exercised 44,250 option-derived shares (code M) on June 30, 2026 at $21.06 per share for a cash cost of $931,905. On the same day he sold 44,250 shares and 41,798 shares in two open-market transactions (code S) at a reported weighted average price of $51.48 per share, generating $2,277,809 and $2,151,648 respectively (total proceeds ≈ $4,429,457). The filing also shows 44,250 derivative shares listed as disposed at $0.00 (see footnote).

Key Details

  • Transaction date: June 30, 2026; Form 4 filed July 1, 2026 (timely).
  • Options exercised: 44,250 shares at $21.06 ($931,905).
  • Sales: 44,250 shares and 41,798 shares at a weighted average of $51.48/share (range $50.98–$52.13); total proceeds ≈ $4,429,457.
  • Additional entry: 44,250 derivative shares reported disposed at $0.00 (often reflects shares surrendered for exercise cost or tax withholding — see footnote).
  • Footnotes: F1 — sales pursuant to a Rule 10b5-1 plan adopted March 31, 2026; F2 — weighted average sale price with per-share range $50.98–$52.13; F3 — option vesting history (half vested Feb 23, 2019; half Feb 23, 2020).
  • Shares owned after the transactions: not specified in the provided excerpt of the Form 4.

Context

  • The filing shows an option exercise followed by same-day sales — a common pattern when executives exercise vested options and sell shares, sometimes under pre-established 10b5-1 plans. The presence of a 10b5-1 plan (F1) indicates these sales were pre-planned, which is often routine and not necessarily a directional signal about the company.

Insider Transaction Report

Form 4
Period: 2026-06-30
Bhojwani Gary C.
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-06-30$21.06/sh+44,250$931,905260,312 total
  • Sale

    Common Stock

    [F1][F2]
    2026-06-30$51.48/sh44,250$2,277,809216,062 total
  • Sale

    Common Stock

    [F1][F2]
    2026-06-30$51.48/sh41,798$2,151,648174,264 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F3]
    2026-06-3044,2500 total
    Exercise: $21.06Exp: 2027-02-23Common Stock (44,250 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    651,189
Footnotes (3)
  • [F1]Shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026.
  • [F2]Reflects the weighted average sale price. For each of the two sale transactions reported on this Form 4, the shares were sold at prices ranging from $50.98 per share to $52.13 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
  • [F3]One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020.
Signature
Heidi M. Krings, Attorney-in-Fact|2026-07-01

Documents

1 file
  • 4
    wk-form4_1782936649.xmlPrimary

    FORM 4